Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.75 |
| ▸ | GAA | P10253 | 3/20 | 0.75 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.75 |
| ▸ | LMNA | P02545 | 2/20 | 0.75 |
| ▸ | HPGD | P15428 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 2/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | NPC1 | O15118 | 1/20 | 0.75 |
| ▸ | RAB9A | P51151 | 1/20 | 0.75 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.75 |
| ▸ | HTT | P42858 | 1/20 | 0.71 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | ACHE | P22303 | 3/20 | 0.57 |
| ▸ | CDC7 | O00311 | 5/20 | 0.56 |
| ▸ | DBF4 | Q9UBU7 | 5/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15976546 | 0.86 | ALDH1A1 (1.00) | ALDH1A1GAASMN1; SMN2LMNAHPGD | |
| SCHEMBL11017680 | 0.84 | HTT (0.76) | ALDH1A1GAASMN1; SMN2LMNAHPGD | |
| SCHEMBL16851068 | 0.82 | GAA (0.79) | ALDH1A1GAASMN1; SMN2LMNAHPGD | |
| SCHEMBL5710179 | 0.81 | HTT (0.70) | ALDH1A1GAASMN1; SMN2LMNAHPGD | |
| Hydrochloric Acid SCHEMBL10377238 | 0.80 | ADORA3 (0.56) | ALDH1A1GAASMN1; SMN2LMNAHPGD | |
| SCHEMBL16851059 | 0.77 | SMN1; SMN2 (0.74) | ALDH1A1GAASMN1; SMN2LMNAHPGD | |
| SCHEMBL14352130 | 0.76 | ALDH1A1 (0.59) | ALDH1A1GAASMN1; SMN2LMNAHPGD | |
| SCHEMBL16851065 | 0.76 | ALDH1A1 (0.67) | ALDH1A1GAASMN1; SMN2LMNAHPGD | |
| SCHEMBL16851064 | 0.76 | SMN1; SMN2 (0.72) | ALDH1A1GAASMN1; SMN2LMNAHPGD | |
| SCHEMBL10377442 | 0.76 | KDM4E (0.65) | ALDH1A1GAASMN1; SMN2LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10179768-B2 | Electrochromic two-core viologen derivatives and optical articles containing them | ESSILOR INTERNATIONAL (FR) | 2019-01-15 | — | — | US | disclosed |
| EP-2848668-B1 | Electrochromic two-core viologen derivatives and optical articles containing them | ESSILOR INT (FR) | 2019-01-09 | — | — | EP | disclosed |
| CN-105555910-B | Electrochromic two-cores viologen derivative and optical article containing the two-cores viologen derivative | 依视路国际公司 | 2018-11-02 | — | — | CN | disclosed |
| US-20160221949-A1 | ELECTROCHROMIC TWO-CORE VIOLOGEN DERIVATIVES AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQU E) (FR) | 2016-08-04 | — | — | US | disclosed |
| CN-105555910-A | Electrochromic two-core viologen derivatives and optical articles containing them | ESSILOR INT CIE GENERALE D'OPTIQUE | 2016-05-04 | — | — | CN | disclosed |
| WO-2015040031-A1 | ELECTROCHROMIC TWO-CORE VIOLOGEN DERIVATIVES AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2015-03-26 | — | — | WO | disclosed |
| WO-2015040031-A1 | ELECTROCHROMIC TWO-CORE VIOLOGEN DERIVATIVES AND OPTICAL ARTICLES CONTAINING THEM | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2015-03-26 | — | — | WO | disclosed |
| EP-2848668-A1 | Electrochromic two-core viologen derivatives and optical articles containing them | ESSILOR INTERNATIONAL (Compagnie Générale d'Optique) (FR) | 2015-03-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160221949-A1 | ELECTROCHROMIC TWO-CORE VIOLOGEN DERIVATIVES AND OPTICAL ARTICLES CONTAINING THEM | EYA2, CRY2, PPOX | ALDH1A1 2634/4885GAA 4625/4885SMN1; SMN2 4767/4885 |
| US-10179768-B2 | Electrochromic two-core viologen derivatives and optical articles containing them | EYA2, CRY2, PPOX | ALDH1A1 2634/4885GAA 4625/4885SMN1; SMN2 4767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.